Search

everythinglearnresearchcommunity

for

Search:↓

Myo-inositol plus α-lactalbumin works better than myo-inositol alone for improving symptoms of PCOS.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

IBD patients treated with TNF antagonists may develop autoimmune alopecia areata, with severe cases less likely to improve.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

iNOS contributes to hair loss in obese diabetic mice and blocking it may encourage hair growth.

Some hair proteins are specific to hair, while others are also found in skin cells.

JAK inhibitors like tofacitinib may effectively treat alopecia in children without major side effects.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Some drugs used to treat immune conditions may cause different types of hair loss.

EGF, IGF-I, and IGF-IR genes are crucial for mink skin and hair growth.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Adalimumab improved folliculitis decalvans in most patients.

Mycophenolate mofetil is a good alternative for autoimmune hepatitis patients who can't tolerate azathioprine.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Alopecia areata patients have higher levels of IL-6 and TNF-α.

Higher antigliadin antibody levels are linked to alopecia areata severity.

Folate receptor β helps suppress the immune system in macrophages and affects cancer growth and hair health.

Too much IKZF1 and Ikaros protein may cause alopecia areata.

Infrared thermography, especially with dermoscopy, improves accuracy in diagnosing active hair loss due to inflammation.

DAB labeling effectively identifies collagen type III and PDGFR in horse skin, but may show false positives.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

HKN-2 antibody targets specific skin and hair cells, showing keratin complexity.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Myo-inositol-based treatments greatly improve pregnancy chances for women with PCOS.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Mycophenolate mofetil improved skin condition in a man with nephrogenic fibrosing dermopathy.

Better nutrition may reduce fecal incontinence in stroke patients by lowering inflammation and improving antioxidant levels.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.